<DOC>
	<DOCNO>NCT02509871</DOCNO>
	<brief_summary>This cross-sectional study pathophysiology bring additional information body composition patient treat adjuvant hormonal therapy breast cancer . This complementary study Metaca study ( AU882 ) .</brief_summary>
	<brief_title>Study Body Composition Patients Treated Adjuvant Hormonal Therapy Breast Cancer ( MetaCa2 )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>postmenopausal woman patient require hormonal treatment WHO performance status 02 patient initially include MetaCa ( AU882 ) protocol Affiliation social security scheme ( beneficiary plan ) patient sign informed consent form patient witg relapse , metastases cancer concurrent treatment drug test , participation clinical trial within &lt; 30 day patient carry electronic medical device ( eg pacemaker ) patient refuse sign consent form</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Body composition</keyword>
</DOC>